Xencor Inc (14) | License Agreements (3)

Recent Contracts

First Amendment to the Research and License Agreement, dated November 22, 2019, by and between the Company and Amgen Inc (Filed With SEC on February 24, 2021)
Second Amendment to the License Agreement, dated January 8, 2020, by and between the Company and MorphoSys AG (Filed With SEC on February 24, 2021)
Third Amendment to the License Agreement, dated July 13, 2020, by and between the Company and MorphoSys AG (Filed With SEC on February 24, 2021)